CME/CE

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.

4869

LikeLikedUnlike

691-705 of 1225

MinuteCE®
Biomarking the Difference: How Second-Generation Therapies are Changing the Game
- Justis P. Ehlers, MD, FASRS
- Roger A. Goldberg, MD, MBA
- Jennifer, I. Lim, MD, FASRS, FARVO
- Ehsan Rahimy, MD
1.00 credits 10 episodes
Signs of Progress: PED as a Predictor of Disease and Outcomes
MinuteCE®
Signs of Progress: PED as a Predictor of Disease and Outcomes
- Justis P. Ehlers, MD, FASRS
- Jennifer, I. Lim, MD, FASRS, FARVO
1.00 program credits
Non-CF Bronchiectasis: How Radiologists Can Drive Better Outcomes
CME/CE
Non-CF Bronchiectasis: How Radiologists Can Drive Better Outcomes
- Robert D. Suh, MD
- Lea Azour, MD
- Ashwin Basavaraj, MD
1.00 credits
Fluid Foundations: How Location Impacts Outcomes in nAMD
MinuteCE®
Fluid Foundations: How Location Impacts Outcomes in nAMD
- Roger A. Goldberg, MD, MBA
- Ehsan Rahimy, MD
1.00 program credits
Early Fluid Resolution – A Key to Long-Term Success
MinuteCE®
Early Fluid Resolution – A Key to Long-Term Success
- Roger A. Goldberg, MD, MBA
- Ehsan Rahimy, MD
1.00 program credits
FSGS in Practice: Patient-Centered Decision-Making
CME/CE
FSGS in Practice: Patient-Centered Decision-Making
- Kenneth Lieberman, MD
- Howard Trachtman, MD, FASN
0.25 credits
advertisement
Second-Generation Biomarkers for Treatment Outcomes
MinuteCE®
Second-Generation Biomarkers for Treatment Outcomes
- Justis P. Ehlers, MD, FASRS
- Jennifer, I. Lim, MD, FASRS, FARVO
1.00 program credits
Beyond Durability - What Biomarkers Reveal About Disease Control
MinuteCE®
Beyond Durability - What Biomarkers Reveal About Disease Control
- Justis P. Ehlers, MD, FASRS
- Jennifer, I. Lim, MD, FASRS, FARVO
1.00 program credits
The Durability Dilemma
MinuteCE®
The Durability Dilemma
- Roger A. Goldberg, MD, MBA
- Ehsan Rahimy, MD
1.00 program credits
Shifting Treatment Paradigm in HFmrEF/HFpEF: Steroidal and Nonsteroidal MRAs
CME/CE
Shifting Treatment Paradigm in HFmrEF/HFpEF: Steroidal and Nonsteroidal MRAs
- Faiez Zannad, MD, PhD
- John McMurray, OBE, BSc, MB ChB (Hons), MD, FRCP, FRSE, FMedSci, FESC, FACC, FAHA, FJCS, FHFA, FHFSA, FBSH
0.25 credits
SHTG: Decoding the Latest Clinical Trial Outcomes
MinuteCE®
SHTG: Decoding the Latest Clinical Trial Outcomes
- Pam R. Taub, MD, FACC, FASPC
- Kausik Ray, MBChB, MD, MPhil
1.00 program credits
Targeting Mixed Hyperlipidemia with APOC3 Inhibition
MinuteCE®
Targeting Mixed Hyperlipidemia with APOC3 Inhibition
- Pam R. Taub, MD, FACC, FASPC
- Kausik Ray, MBChB, MD, MPhil
1.00 program credits
advertisement
Latest Clinical Trial Outcomes and Breakthroughs for FCS
MinuteCE®
Latest Clinical Trial Outcomes and Breakthroughs for FCS
- Daniel Gaudet, MD, PhD
- Pam R. Taub, MD, FACC, FASPC
1.00 program credits
Remnant Cholesterol: The Missing Link in ASCVD risk
MinuteCE®
Remnant Cholesterol: The Missing Link in ASCVD risk
- Børge G. Nordestgaard, MD, DMSc
- Kausik Ray, MBChB, MD, MPhil
1.00 program credits
SHTG: Defining the Unmet Clinical Need
MinuteCE®
SHTG: Defining the Unmet Clinical Need
- Pam R. Taub, MD, FACC, FASPC
- Kausik Ray, MBChB, MD, MPhil
1.00 program credits